This document discusses antigens and antibodies. It defines antigens as any molecule that can bind specifically to an antibody. Antigens include sugars, lipids, proteins and more. They can be found on microbes or in the environment. The document discusses the properties of antigens including their ability to induce immune responses or tolerance. It also discusses immunogens versus haptens. Factors that influence antigen immunogenicity are also covered such as molecular size, composition, and an antigen's susceptibility to processing and presentation. The role of adjuvants in enhancing immune responses is also summarized.
The document discusses the major histocompatibility complex (MHC) in mammals. It notes that MHC acts as antigen presenting receptors and are involved in cell-cell interaction, antigen presentation, and recognition of self and non-self molecules. MHC is found on chromosome 6 in humans and is referred to as the HLA complex. MHC molecules are divided into three main classes - Class I MHC present antigens to cytotoxic T cells, Class II MHC present antigens to helper T cells, and Class III MHC genes encode complement components and cytokines. The structures and functions of Class I and Class II MHC molecules are described in detail.
The innate immune response is the first line of defense against infection and predates the adaptive immune response. It uses germline-encoded pattern recognition receptors (PRRs) to recognize pathogen-associated molecular patterns (PAMPs) and initiate a proinflammatory response. The major PRR families are Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), NOD-like receptors (NLRs), and C-type lectin receptors (CLRs). TLRs recognize bacteria and viruses at the cell surface and within endosomes, and signal through either the MyD88 or TRIF adaptor pathways to induce inflammatory cytokines and type I interferons. NLRs and RLRs function
Cytokines are proteins that are involved in cell signaling and communication during immune responses and inflammation. They modulate processes like immune cell differentiation, activation of lymphocytes and phagocytes, and the development of adaptive immunity. Corticosteroids suppress immunity by blocking cytokine synthesis and release. Cytokines play roles in diseases like cancer, rheumatoid arthritis, and septic shock by regulating immune and inflammatory processes. They can be measured clinically to monitor certain conditions.
This document discusses immunosuppression and immune tolerance. It defines immunosuppression as a state of temporary or permanent dysfunction of the immune response, and describes some causes as diseases or drugs used before organ transplants. It also discusses immune tolerance, including the concept of self-tolerance and how the immune system distinguishes self from foreign antigens. Theories of tolerance include clonal deletion and anergy. Mechanisms of tolerance include central tolerance in the thymus and bone marrow for T and B cells, and peripheral tolerance for self-reactive cells that escape central tolerance checks. Failure of tolerance can lead to autoimmune diseases.
1) The document discusses cancer and the immune system, covering topics like tumor antigens, immune responses to tumors, and tumor escape mechanisms.
2) It provides an overview of tumor immunology, including how tumors evade the immune system through mechanisms like down-regulating class I MHC expression and antigen modulation.
3) The document also summarizes different immunotherapy approaches, such as treatments using cytokines, monoclonal antibodies, and vaccination strategies using isolated tumor peptides or transfected tumor cells.
T CELL ACTIVATION AND IT'S TERMINATIONpremvarma064
T cell activation requires two signals: 1) recognition of antigens displayed on antigen-presenting cells by T cell receptors and 2) co-stimulatory signals through molecules like CD28. This leads T cells to proliferate, differentiate into effector and memory cells, and perform effector functions. Proper activation requires interaction between T cells and antigen-presenting cells in lymphoid tissues, where costimulatory molecules are highly expressed. Dysregulation of T cell activation can lead to autoimmunity or susceptibility to infection.
The immunological synapse is a specialized signaling structure formed at the interface between T lymphocytes and antigen presenting cells. It consists of three main components: T cell receptors, adhesion molecules, and co-stimulatory molecules. Formation of the mature immunological synapse involves molecular redistribution through diffusion and cytoskeletal movement over 5-30 minutes, resulting in a structure with central, peripheral, and distal supramolecular activation clusters that facilitate T cell signaling and activation. This signaling activates transcription factors that induce cytokine gene expression and T cell effector functions.
The document discusses the major histocompatibility complex (MHC) in mammals. It notes that MHC acts as antigen presenting receptors and are involved in cell-cell interaction, antigen presentation, and recognition of self and non-self molecules. MHC is found on chromosome 6 in humans and is referred to as the HLA complex. MHC molecules are divided into three main classes - Class I MHC present antigens to cytotoxic T cells, Class II MHC present antigens to helper T cells, and Class III MHC genes encode complement components and cytokines. The structures and functions of Class I and Class II MHC molecules are described in detail.
The innate immune response is the first line of defense against infection and predates the adaptive immune response. It uses germline-encoded pattern recognition receptors (PRRs) to recognize pathogen-associated molecular patterns (PAMPs) and initiate a proinflammatory response. The major PRR families are Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), NOD-like receptors (NLRs), and C-type lectin receptors (CLRs). TLRs recognize bacteria and viruses at the cell surface and within endosomes, and signal through either the MyD88 or TRIF adaptor pathways to induce inflammatory cytokines and type I interferons. NLRs and RLRs function
Cytokines are proteins that are involved in cell signaling and communication during immune responses and inflammation. They modulate processes like immune cell differentiation, activation of lymphocytes and phagocytes, and the development of adaptive immunity. Corticosteroids suppress immunity by blocking cytokine synthesis and release. Cytokines play roles in diseases like cancer, rheumatoid arthritis, and septic shock by regulating immune and inflammatory processes. They can be measured clinically to monitor certain conditions.
This document discusses immunosuppression and immune tolerance. It defines immunosuppression as a state of temporary or permanent dysfunction of the immune response, and describes some causes as diseases or drugs used before organ transplants. It also discusses immune tolerance, including the concept of self-tolerance and how the immune system distinguishes self from foreign antigens. Theories of tolerance include clonal deletion and anergy. Mechanisms of tolerance include central tolerance in the thymus and bone marrow for T and B cells, and peripheral tolerance for self-reactive cells that escape central tolerance checks. Failure of tolerance can lead to autoimmune diseases.
1) The document discusses cancer and the immune system, covering topics like tumor antigens, immune responses to tumors, and tumor escape mechanisms.
2) It provides an overview of tumor immunology, including how tumors evade the immune system through mechanisms like down-regulating class I MHC expression and antigen modulation.
3) The document also summarizes different immunotherapy approaches, such as treatments using cytokines, monoclonal antibodies, and vaccination strategies using isolated tumor peptides or transfected tumor cells.
T CELL ACTIVATION AND IT'S TERMINATIONpremvarma064
T cell activation requires two signals: 1) recognition of antigens displayed on antigen-presenting cells by T cell receptors and 2) co-stimulatory signals through molecules like CD28. This leads T cells to proliferate, differentiate into effector and memory cells, and perform effector functions. Proper activation requires interaction between T cells and antigen-presenting cells in lymphoid tissues, where costimulatory molecules are highly expressed. Dysregulation of T cell activation can lead to autoimmunity or susceptibility to infection.
The immunological synapse is a specialized signaling structure formed at the interface between T lymphocytes and antigen presenting cells. It consists of three main components: T cell receptors, adhesion molecules, and co-stimulatory molecules. Formation of the mature immunological synapse involves molecular redistribution through diffusion and cytoskeletal movement over 5-30 minutes, resulting in a structure with central, peripheral, and distal supramolecular activation clusters that facilitate T cell signaling and activation. This signaling activates transcription factors that induce cytokine gene expression and T cell effector functions.
This document defines key terms related to antigens and the immune response. It discusses how antigens stimulate an immune response by interacting with antibodies and T cells. There are different types of antigens including exogenous antigens that enter the body from outside, endogenous antigens generated inside cells, autoantigens that are recognized by the immune system in autoimmune diseases, and tumor antigens expressed by cancer cells. The document also describes properties of antigens like immunogenicity and antigenicity, and characteristics of antigenic epitopes recognized by B cells and T cells. It classifies antigens as thymus-dependent or -independent and discusses conventional antigens, superantigens, and adjuvants that enhance immune responses.
Dendritic cells are bone marrow-derived antigen-presenting cells that initiate adaptive immune responses. They capture antigens through processes like endocytosis and present them on MHC molecules to activate T cells. Dendritic cells exist in immature and mature forms, and upon maturation they migrate from tissues to lymph nodes to activate T cells. As the most potent antigen-presenting cells, dendritic cells play a key role in anti-cancer immunity by presenting tumor antigens, activating T cells, and generating an immune response against cancer cells.
Immune tolerance is induced through central and peripheral mechanisms that eliminate or suppress self-reactive immune cells. Central tolerance occurs in the thymus and bone marrow where high-affinity self-reactive T and B cells undergo apoptosis or receptor editing. Peripheral tolerance includes anergy induction, suppression by regulatory T cells (Tregs), and inhibition by receptors like CTLA-4 and PD-1. Tregs expressing the transcription factor FoxP3 are critical for maintaining tolerance and preventing autoimmunity. Failure of these tolerance mechanisms can lead to autoimmune disease.
Autophagy plays multifaceted roles in both the innate and adaptive immune system. In innate immunity, autophagy aids in the recognition of pathogens by pattern recognition receptors like TLRs, NLRs, and RLRs. It also facilitates the handling and destruction of intracellular bacteria by phagocytosis and lysosomal fusion. Autophagy regulates the production of cytokines as well. In adaptive immunity, autophagy contributes to antigen presentation on MHC class I and II molecules and is important for the homeostasis and functions of lymphocytes like T cells and B cells. However, the precise mechanisms in some cases require further clarification.
Regulatory T-cells (Tregs) help maintain self-tolerance and prevent autoimmunity by suppressing immune responses. They express FOXP3 and CD25 and function through various mechanisms like secreting inhibitory cytokines or metabolizing IL-2. Tregs are implicated in tumor immune escape by suppressing anti-tumor immunity. While Tregs are normally beneficial, in cancer high levels associate with poor prognosis by hindering immune response. Emerging immunotherapies aim to deplete or modulate Tregs to enhance anti-tumor immunity.
- Edward Jenner is considered the father of immunology for his pioneering work in the late 1700s demonstrating that exposure to cowpox conferred immunity to smallpox. He inoculated an 8-year old boy with cowpox who was then resistant to smallpox.
- Over subsequent decades, scientists isolated various pathogens and discovered antibodies, antitoxins, and defined antigens, advancing the understanding of the immune system and leading to treatments for diseases like diphtheria and tetanus.
- Major discoveries in the 20th century included identification of blood groups, acquired immunological tolerance, monoclonal antibodies, and genetic principles underlying antibody diversity. These advances furthered knowledge of immunity and laid the foundations for
- Naive B cells express IgM and IgD antibodies on their surface that recognize antigens. Upon activation, a single B cell can produce up to 10^12 antibody molecules per day through plasma cell differentiation.
- Repeated antigen exposure leads to affinity maturation through somatic hypermutation in germinal centers, increasing antibody affinity over time. Helper T cells are required for isotype switching and affinity maturation.
- Engagement of complement receptors and toll-like receptors enhances B cell activation and antibody production. Activated B cells also upregulate costimulators to amplify helper T cell responses.
This document discusses immunoregulation and the various mechanisms that regulate immune responses. It describes how regulatory mechanisms act at all phases of the immune response, including recognition, activation, and effector function. Cytokines and regulatory T cells are highlighted as key regulators that can either stimulate or inhibit immune responses. The role of genetic factors in influencing immunoregulation is also summarized, noting genes related to immunoglobulins, T-cell receptors, and MHC complexes.
This document defines key immunological concepts such as antigens, immunogens, epitopes, haptens, cross-reactivity, mitogens, and superantigens. It explains that antigens are substances that induce an immune response, while immunogens are antigens that specifically induce an effective immune response. It also discusses the differences between B cell and T cell antigen recognition and factors that influence antigen immunogenicity.
1) The document discusses innate immunity, which provides the first line of host defense against infection through recognition of microbial and damaged self molecules. (2) It describes the cellular and soluble components of innate immunity, including phagocytes, dendritic cells, NK cells, complement proteins, and antimicrobial peptides. (3) Pattern recognition receptors (PRRs) play a key role in innate immunity by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) to initiate inflammatory responses and stimulate adaptive immunity.
This document summarizes the innate immune system. It describes the four types of defensive barriers: anatomic, physiologic, phagocytic, and inflammatory. The anatomic barriers include skin and mucous membranes. The physiologic barriers include low pH levels, chemicals that inhibit microbes, and fever. Phagocytic barriers involve white blood cells that ingest pathogens. The inflammatory response causes redness, pain, heat and swelling at sites of infection. Key cells that participate in innate immunity are also discussed.
Cytokines are small, secreted proteins that are involved in cell signaling and communication. They are produced by a variety of cells and act on many cells of the immune system. Cytokines have a variety of functions including regulating inflammation, immune cell development, and cell migration. They are classified into families based on their structure and activities. Examples include interleukins, interferons, tumor necrosis factors, chemokines, and colony stimulating factors. Cytokines act through specific cell surface receptors and have complex, overlapping roles in the immune system.
Immunoglobulins are glycoprotein antibodies produced by plasma cells in response to antigens. They have Y-shaped structures composed of two heavy chains and two light chains connected by disulfide bonds. The variable regions at the tips of the Y determine antigen binding specificity, while the constant regions mediate effector functions like complement activation. The five major classes in humans are IgG, IgM, IgA, IgD, and IgE, which have different structures, properties, and roles in immunity.
Toll-like receptors (TLRs) are a key part of the innate immune system. They recognize structural patterns in pathogens and activate immune responses. TLRs are expressed in immune cells and tissues exposed to the external environment. They recognize pathogen-associated molecular patterns and signal through either a MyD88-dependent or TRIF-dependent pathway to induce inflammatory responses and help activate adaptive immunity. TLR signaling leads to cytokine production, phagocytosis, cell apoptosis, and interferon release. This helps link innate and adaptive immunity through effects on dendritic cells.
Immunological tolerance occurs when the immune system does not attack the body's own tissues. Central tolerance occurs during lymphocyte development and eliminates self-reactive cells. Peripheral tolerance maintains tolerance after lymphocytes leave the primary organs. Mechanisms of central tolerance include deletion of self-reactive T and B cells in the thymus and bone marrow. Peripheral tolerance prevents autoimmunity through deletion, anergy, and ignorance of self-reactive cells in secondary lymphoid tissues. Immunological tolerance is crucial for distinguishing self from non-self and preventing autoimmune disease.
The major histocompatibility complex (MHC) is a set of genes that code for cell surface proteins essential for the acquired immune system to recognize foreign molecules in vertebrates. Peptides from intracellular pathogens are carried to the cell surface by MHC class I and MHC class II and presented to CD4 T cells. Antigen presenting cells like dendritic cells, macrophages, and B cells present MHC class II antigens to CD4 T cells, while all nucleated cells present MHC class I antigens.
1. Antigen processing and presentation involves degradation of antigens into peptides, association of peptides with MHC molecules, and display of peptide-MHC complexes on the cell surface for recognition by T cells.
2. There are two main pathways of antigen processing - exogenous antigens that enter the cell are processed through the endocytic pathway while endogenous antigens are processed through the cytosolic pathway.
3. In the cytosolic pathway, antigens are degraded by the proteasome and transported by TAP into the ER where they can bind to MHC class I molecules. In the endocytic pathway, exogenous antigens internalized into vesicles are degraded into peptides that bind MHC class II molecules.
Antigens are substances that stimulate the immune system to produce antibodies against them. They enter the body through various sites and are then captured and presented by antigen presenting cells. There are several types of antigens including immunogens, which induce immune responses; tolerogens, which induce tolerance; allergens; and vaccines. An antigen's ability to induce an immune response is called its immunogenicity, while its ability to bind antibodies is its antigenicity. Properties that influence immunogenicity include the antigen's foreignness, size, complexity, degradability, and the recipient's genotype and age. Administration methods like dosage, route, and use of adjuvants can also impact immunogenicity. Antigens are classified as complete if they have
This document discusses antigen processing. It provides evidence that:
1) Antigens must be processed to be recognized by T cells, as T cells do not recognize native antigens. Antigen processing involves uptake, degradation, complex formation and presentation.
2) Antigen processing can take place in lysosomes, as extracellular antigens are dealt with by the lysosomal system. However, a non-lysosomal mechanism is also required to process intracellular antigens from viruses that infect most cell types.
3) Infectious viruses use the cellular protein synthesis machinery to replicate and generate antigens through a non-lysosomal pathway, while inactivated viruses are processed through the lysosomal pathway to generate antigens recognized by some CTLs
Cell-mediated immunity involves T lymphocytes that combat intracellular microbes. There are two phases: activation of naive T cells by antigen-presenting cells in lymphoid tissues, followed by migration of effector T cells to sites of infection. Effector T cells differentiate into subsets like TH1 and TH2 cells that secrete cytokines activating other immune cells. CD8+ T cells become cytotoxic T lymphocytes that directly kill infected cells. Memory T cells remain after infection clearance to provide rapid protection upon reexposure.
This document defines key terms related to antigens and the immune response. It discusses how antigens stimulate an immune response by interacting with antibodies and T cells. There are different types of antigens including exogenous antigens that enter the body from outside, endogenous antigens generated inside cells, autoantigens that are recognized by the immune system in autoimmune diseases, and tumor antigens expressed by cancer cells. The document also describes properties of antigens like immunogenicity and antigenicity, and characteristics of antigenic epitopes recognized by B cells and T cells. It classifies antigens as thymus-dependent or -independent and discusses conventional antigens, superantigens, and adjuvants that enhance immune responses.
Dendritic cells are bone marrow-derived antigen-presenting cells that initiate adaptive immune responses. They capture antigens through processes like endocytosis and present them on MHC molecules to activate T cells. Dendritic cells exist in immature and mature forms, and upon maturation they migrate from tissues to lymph nodes to activate T cells. As the most potent antigen-presenting cells, dendritic cells play a key role in anti-cancer immunity by presenting tumor antigens, activating T cells, and generating an immune response against cancer cells.
Immune tolerance is induced through central and peripheral mechanisms that eliminate or suppress self-reactive immune cells. Central tolerance occurs in the thymus and bone marrow where high-affinity self-reactive T and B cells undergo apoptosis or receptor editing. Peripheral tolerance includes anergy induction, suppression by regulatory T cells (Tregs), and inhibition by receptors like CTLA-4 and PD-1. Tregs expressing the transcription factor FoxP3 are critical for maintaining tolerance and preventing autoimmunity. Failure of these tolerance mechanisms can lead to autoimmune disease.
Autophagy plays multifaceted roles in both the innate and adaptive immune system. In innate immunity, autophagy aids in the recognition of pathogens by pattern recognition receptors like TLRs, NLRs, and RLRs. It also facilitates the handling and destruction of intracellular bacteria by phagocytosis and lysosomal fusion. Autophagy regulates the production of cytokines as well. In adaptive immunity, autophagy contributes to antigen presentation on MHC class I and II molecules and is important for the homeostasis and functions of lymphocytes like T cells and B cells. However, the precise mechanisms in some cases require further clarification.
Regulatory T-cells (Tregs) help maintain self-tolerance and prevent autoimmunity by suppressing immune responses. They express FOXP3 and CD25 and function through various mechanisms like secreting inhibitory cytokines or metabolizing IL-2. Tregs are implicated in tumor immune escape by suppressing anti-tumor immunity. While Tregs are normally beneficial, in cancer high levels associate with poor prognosis by hindering immune response. Emerging immunotherapies aim to deplete or modulate Tregs to enhance anti-tumor immunity.
- Edward Jenner is considered the father of immunology for his pioneering work in the late 1700s demonstrating that exposure to cowpox conferred immunity to smallpox. He inoculated an 8-year old boy with cowpox who was then resistant to smallpox.
- Over subsequent decades, scientists isolated various pathogens and discovered antibodies, antitoxins, and defined antigens, advancing the understanding of the immune system and leading to treatments for diseases like diphtheria and tetanus.
- Major discoveries in the 20th century included identification of blood groups, acquired immunological tolerance, monoclonal antibodies, and genetic principles underlying antibody diversity. These advances furthered knowledge of immunity and laid the foundations for
- Naive B cells express IgM and IgD antibodies on their surface that recognize antigens. Upon activation, a single B cell can produce up to 10^12 antibody molecules per day through plasma cell differentiation.
- Repeated antigen exposure leads to affinity maturation through somatic hypermutation in germinal centers, increasing antibody affinity over time. Helper T cells are required for isotype switching and affinity maturation.
- Engagement of complement receptors and toll-like receptors enhances B cell activation and antibody production. Activated B cells also upregulate costimulators to amplify helper T cell responses.
This document discusses immunoregulation and the various mechanisms that regulate immune responses. It describes how regulatory mechanisms act at all phases of the immune response, including recognition, activation, and effector function. Cytokines and regulatory T cells are highlighted as key regulators that can either stimulate or inhibit immune responses. The role of genetic factors in influencing immunoregulation is also summarized, noting genes related to immunoglobulins, T-cell receptors, and MHC complexes.
This document defines key immunological concepts such as antigens, immunogens, epitopes, haptens, cross-reactivity, mitogens, and superantigens. It explains that antigens are substances that induce an immune response, while immunogens are antigens that specifically induce an effective immune response. It also discusses the differences between B cell and T cell antigen recognition and factors that influence antigen immunogenicity.
1) The document discusses innate immunity, which provides the first line of host defense against infection through recognition of microbial and damaged self molecules. (2) It describes the cellular and soluble components of innate immunity, including phagocytes, dendritic cells, NK cells, complement proteins, and antimicrobial peptides. (3) Pattern recognition receptors (PRRs) play a key role in innate immunity by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) to initiate inflammatory responses and stimulate adaptive immunity.
This document summarizes the innate immune system. It describes the four types of defensive barriers: anatomic, physiologic, phagocytic, and inflammatory. The anatomic barriers include skin and mucous membranes. The physiologic barriers include low pH levels, chemicals that inhibit microbes, and fever. Phagocytic barriers involve white blood cells that ingest pathogens. The inflammatory response causes redness, pain, heat and swelling at sites of infection. Key cells that participate in innate immunity are also discussed.
Cytokines are small, secreted proteins that are involved in cell signaling and communication. They are produced by a variety of cells and act on many cells of the immune system. Cytokines have a variety of functions including regulating inflammation, immune cell development, and cell migration. They are classified into families based on their structure and activities. Examples include interleukins, interferons, tumor necrosis factors, chemokines, and colony stimulating factors. Cytokines act through specific cell surface receptors and have complex, overlapping roles in the immune system.
Immunoglobulins are glycoprotein antibodies produced by plasma cells in response to antigens. They have Y-shaped structures composed of two heavy chains and two light chains connected by disulfide bonds. The variable regions at the tips of the Y determine antigen binding specificity, while the constant regions mediate effector functions like complement activation. The five major classes in humans are IgG, IgM, IgA, IgD, and IgE, which have different structures, properties, and roles in immunity.
Toll-like receptors (TLRs) are a key part of the innate immune system. They recognize structural patterns in pathogens and activate immune responses. TLRs are expressed in immune cells and tissues exposed to the external environment. They recognize pathogen-associated molecular patterns and signal through either a MyD88-dependent or TRIF-dependent pathway to induce inflammatory responses and help activate adaptive immunity. TLR signaling leads to cytokine production, phagocytosis, cell apoptosis, and interferon release. This helps link innate and adaptive immunity through effects on dendritic cells.
Immunological tolerance occurs when the immune system does not attack the body's own tissues. Central tolerance occurs during lymphocyte development and eliminates self-reactive cells. Peripheral tolerance maintains tolerance after lymphocytes leave the primary organs. Mechanisms of central tolerance include deletion of self-reactive T and B cells in the thymus and bone marrow. Peripheral tolerance prevents autoimmunity through deletion, anergy, and ignorance of self-reactive cells in secondary lymphoid tissues. Immunological tolerance is crucial for distinguishing self from non-self and preventing autoimmune disease.
The major histocompatibility complex (MHC) is a set of genes that code for cell surface proteins essential for the acquired immune system to recognize foreign molecules in vertebrates. Peptides from intracellular pathogens are carried to the cell surface by MHC class I and MHC class II and presented to CD4 T cells. Antigen presenting cells like dendritic cells, macrophages, and B cells present MHC class II antigens to CD4 T cells, while all nucleated cells present MHC class I antigens.
1. Antigen processing and presentation involves degradation of antigens into peptides, association of peptides with MHC molecules, and display of peptide-MHC complexes on the cell surface for recognition by T cells.
2. There are two main pathways of antigen processing - exogenous antigens that enter the cell are processed through the endocytic pathway while endogenous antigens are processed through the cytosolic pathway.
3. In the cytosolic pathway, antigens are degraded by the proteasome and transported by TAP into the ER where they can bind to MHC class I molecules. In the endocytic pathway, exogenous antigens internalized into vesicles are degraded into peptides that bind MHC class II molecules.
Antigens are substances that stimulate the immune system to produce antibodies against them. They enter the body through various sites and are then captured and presented by antigen presenting cells. There are several types of antigens including immunogens, which induce immune responses; tolerogens, which induce tolerance; allergens; and vaccines. An antigen's ability to induce an immune response is called its immunogenicity, while its ability to bind antibodies is its antigenicity. Properties that influence immunogenicity include the antigen's foreignness, size, complexity, degradability, and the recipient's genotype and age. Administration methods like dosage, route, and use of adjuvants can also impact immunogenicity. Antigens are classified as complete if they have
This document discusses antigen processing. It provides evidence that:
1) Antigens must be processed to be recognized by T cells, as T cells do not recognize native antigens. Antigen processing involves uptake, degradation, complex formation and presentation.
2) Antigen processing can take place in lysosomes, as extracellular antigens are dealt with by the lysosomal system. However, a non-lysosomal mechanism is also required to process intracellular antigens from viruses that infect most cell types.
3) Infectious viruses use the cellular protein synthesis machinery to replicate and generate antigens through a non-lysosomal pathway, while inactivated viruses are processed through the lysosomal pathway to generate antigens recognized by some CTLs
Cell-mediated immunity involves T lymphocytes that combat intracellular microbes. There are two phases: activation of naive T cells by antigen-presenting cells in lymphoid tissues, followed by migration of effector T cells to sites of infection. Effector T cells differentiate into subsets like TH1 and TH2 cells that secrete cytokines activating other immune cells. CD8+ T cells become cytotoxic T lymphocytes that directly kill infected cells. Memory T cells remain after infection clearance to provide rapid protection upon reexposure.
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
This document summarizes several viral infections including measles, mumps, poliovirus, viral hemorrhagic fevers, herpes viruses, cytomegalovirus, varicella-zoster virus, hepatitis B virus, Epstein-Barr virus, and human papillomaviruses. It describes the viruses that cause each infection, how they are transmitted, the path they take in the body, clinical manifestations, morphologic findings, and potential complications. Chronic infections like herpes viruses and hepatitis B are able to evade the immune system and cause long-term infections while others like measles and mumps typically cause acute, transient infections.
The document summarizes a biology lecture on hypersensitivities and immunity to infectious diseases. It discusses the four types of hypersensitivities - type I or immediate hypersensitivity, type II or cytotoxic hypersensitivity, type III or immune complex-mediated hypersensitivity, and type IV or delayed hypersensitivity. It also covers immunity against various infectious agents such as viruses, bacteria, fungi, parasites and emerging/re-emerging infections. The lecture focuses on innate and adaptive immune responses mounted by the host against infectious diseases.
This document provides an overview of biodiversity in the Philippines. It begins by defining key terms like endemism. It then discusses the high plant diversity in the Philippines, noting there are an estimated 12,000 plant species, with many ferns, orchids, and mosses being endemic. The document highlights some examples of endemic species within these groups. It also addresses the country's status as one of 17 megadiverse countries and notes the large numbers of endemic animal species like birds, mammals, and reptiles found in the Philippines. Threats to the country's biodiversity like habitat loss are also examined.
This document provides an overview of immunodeficiency diseases. It describes how immunodeficiencies can be primary, due to abnormalities in immune system development, or secondary, resulting from other diseases or conditions. The major classifications of primary immunodeficiencies are then outlined, including humoral deficiencies affecting B cells, cellular deficiencies affecting T cells, combined deficiencies, and disorders of complement and phagocytosis. Several specific primary immunodeficiency diseases are then described in more detail. Secondary immunodeficiencies resulting from external factors like malnutrition, infection, or drugs are also briefly discussed.
Specific antibody deficiency is characterized by a failure to respond to polysaccharide antigens, leading to recurrent sinopulmonary infections, despite normal immunoglobulin levels and response to protein antigens. It has a variety of clinical and immunological phenotypes that can be transient or permanent. Diagnosis involves evaluating the pattern of infections and measuring pneumococcal antibody levels before and after vaccination. Management includes immunizations, antibiotic prophylaxis and treatment, and potentially immunoglobulin replacement therapy to prevent organ damage from infections. With proper treatment, the prognosis is generally good, but permanent sequelae can occur if left undiagnosed or untreated.
This document provides an overview of immunoglobulin gene families and antibody diversity. It discusses the organization and expression of light chain and heavy chain gene families, including multiple V and C region genes separated by introns on different chromosomes. During B cell development, DNA rearrangements bring a V gene next to a J region (and D region for heavy chains), which allows transcription and expression of a single antibody gene from the multiple gene segments. This genetic rearrangement and alternative splicing mechanisms contribute greatly to antibody diversity.
This document summarizes cell-mediated effector response biology. It discusses how cell-mediated immunity detects and eliminates intracellular pathogens and tumor cells through cells like CD8+ cytotoxic T lymphocytes and cytokine-secreting CD4+ T cells. It describes the mechanisms by which cytotoxic T cells and natural killer cells kill infected or abnormal cells through directed release of cytotoxic proteins or interaction of membrane-bound ligands and receptors on target cells.
This document provides an overview of basic concepts in health planning. It discusses that health planning is a process that culminates in decisions around future health facilities and services to meet community needs. There are different types of planning based on time frame (short, medium, long term) and hierarchy of goals (health policy, program, operational). Effective health planning is multidisciplinary, takes a multisectoral approach, and involves teamwork. The key steps in health planning include situation analysis, problem identification and prioritization, setting goals and targets, determining and analyzing strategies, identifying major activities, developing a budget, and establishing monitoring and evaluation.
Advanced Immunology: Antigen Processing and PresentationHercolanium GDeath
1. Antigens are internalized by antigen presenting cells through endocytosis and degraded within lysosomes into peptide fragments.
2. Peptide fragments from extracellular antigens bind to MHC class II molecules within antigen processing vesicles. The vesicles containing MHC class II-peptide complexes fuse with the cell membrane and present the complexes to CD4+ T cells.
3. Peptide fragments from intracellular antigens are degraded by the proteasome and transported into the endoplasmic reticulum by TAP proteins. The peptides bind to MHC class I molecules and the complexes are presented on the cell surface to CD8+ T cells.
This document discusses immunological tolerance and regulatory T cells. It defines tolerance as unresponsiveness to antigen induced by previous exposure. Central tolerance occurs in the thymus through deletion of self-reactive T cells. Peripheral tolerance occurs through several mechanisms in tissues, including regulatory T cells that suppress immune responses. The key transcription factor controlling regulatory T cells is FOXP3. Mutations in FOXP3 can lead to immune dysregulation diseases like IPEX syndrome.
This document contains an outline of lecture topics covering virology, medical microbiology, environmental microbiology, and industrial microbiology. The virology section includes figures and tables on virus isolation. The medical microbiology section covers pathogenicity, diseases, and microbial relationships. Environmental microbiology discusses water and food microbiology. Industrial microbiology focuses on microbes relevant to food production and other industries.
This document outlines the syllabus for a Biology 151 immunology course. It includes the course description, objectives, calendar of activities, requirements and policies. The course covers the structure and function of the immune system, antigens and antibodies, innate and adaptive immunity, immunodeficiencies, and vaccines. It is comprised of lectures, laboratory sessions, exams and a group presentation on vaccine challenges. The grading is based on exam scores, quizzes, reports and performance.
An overview of primary immunodeficiency diseases 2014avicena1
This document provides an overview of primary immunodeficiency disorders (PIDs). It discusses the key roles of the immune system, host immune defense mechanisms including innate and acquired immunity, types of immunodeficiencies including defects in immune system components, clinical features of PIDs, accurate diagnosis and classification of PIDs, prevalence of PIDs, PID classification systems, immunopathologic basis of PID including major host defense deficiencies, primary antibody disorders, T cell/combined immunodeficiencies including severe combined immunodeficiency, and other forms of immunodeficiencies.
This document discusses immunity to various infectious diseases. It covers innate and adaptive immunity, immunity to viruses, bacteria, fungi, protozoa and helminths. For bacteria, both extracellular and intracellular types are discussed. The roles of antibodies and cell-mediated responses are described for different pathogens depending on where they reside in the host. Mechanisms by which pathogens evade immunity are also summarized.
This document provides an overview of immunodeficiency. It defines immunodeficiency and discusses primary and secondary immunodeficiencies. It describes the immune system and its four arms. It discusses various types of primary immunodeficiencies that affect B cells, T cells, phagocytes, and complement pathways. It also discusses common variable immunodeficiency and selective IgA deficiency. Secondary immunodeficiencies caused by AIDS, cancer, diabetes, transplantation, autoimmune diseases, steroids, asplenia, and aging are summarized. Tests for evaluating immunodeficiency and treatment options are briefly outlined.
This document discusses primary immunodeficiencies, which are a group of genetically determined disorders characterized by impaired immune response. It defines several types of primary immunodeficiencies including SCID, XLA, DiGeorge syndrome, Ataxia-teleangectesia, Wiskott-Aldrich syndrome, and CGD. For each, it describes the genetic cause, characteristic infections, clinical features, and available therapies. The document provides an overview of primary immunodeficiencies for educational purposes.
This document discusses a case presentation of a 2-year-old boy named D. George who has been brought in by his parents due to concerns about recurrent infections. The boy has a history of frequent upper respiratory infections and ear infections, and has been hospitalized twice for infections. The document provides background on primary immunodeficiency diseases and different aspects of the immune system to help evaluate the child's condition and determine if he has an immunodeficiency.
The document discusses the nature of antigens and the major histocompatibility complex (MHC). It defines immunogens and antigens, noting that immunogens can trigger an immune response while not all antigens are immunogens. Antigens are usually large proteins or polysaccharides from foreign organisms. Factors like age, health, dose, and route of exposure can influence the immune response. The document also discusses epitopes, haptens, adjuvants, and the relationship of antigens to the host (autoantigens, alloantigens, heteroantigens). It provides details on MHC genes, class I and class II MHC structure and function in antigen processing and presentation to T cells.
Antigen and antibody are essential components of the immune system. Antigens are substances that induce an immune response through the production of antibodies. The key properties of antigens are that they are foreign, have specific epitopes that antibodies bind to, and can range in size. Antibodies are Y-shaped proteins produced by B cells in response to antigens. The five major classes of antibodies are IgG, IgM, IgA, IgD, and IgE, which have different structures and functions such as pathogen neutralization, opsonization, and activation of immune cells.
1. An immunogen is an agent capable of inducing an immune response, while an antigen is any agent capable of binding to components of the immune system. All immunogens are antigens, but not all antigens are immunogens.
2. Haptens are low molecular weight compounds that are incapable of inducing an immune response alone but can do so when conjugated to a carrier molecule like a protein.
3. For a substance to be immunogenic, it must be foreign, have a high molecular weight and chemical complexity, be degradable, and interact with MHC molecules.
This document discusses antigens and haptens. It defines antigens as macromolecules that elicit an immune response through antibody formation. It classifies antigens as exogenous or endogenous, and further divides endogenous antigens. It distinguishes immunogenicity from antigenicity and defines haptens as low molecular weight compounds that are antigenic but not immunogenic unless coupled to a carrier protein. It provides examples of haptens and describes tests used to detect antigens and haptens.
Antigens are substances that induce detectable immune responses when introduced to an animal host. They bind specifically to antibodies or T-cell receptors. Immunogens are antigens that generate an immune response, while not all antigens are immunogenic. Factors like molecular size, complexity, number of epitopes, dosage, and route of administration affect a substance's immunogenicity. Epitopes are the specific regions on antigens that trigger immune reactions. Haptens are small molecules that become immunogenic when attached to larger carrier molecules. Adjuvants are substances that enhance immune responses to antigens when co-administered.
1) An antigen is any substance that can induce an immune response by being immunogenic or antigenic. Immunogenicity is the ability to induce an immune response through B and T cells. Antigenicity is the ability to bind to antibodies or T cell receptors.
2) An epitope is the smallest part of an antigen that can induce an immune response. It consists of 4-5 amino acids or sugars that bind to T or B cell receptors.
3) A hapten is a small molecule that is not immunogenic on its own but can bind antibodies when attached to a larger carrier molecule, making it immunogenic.
Here are five things to know about coronavirus tests: PCR and antigen tests are the most common but they work differently. While antigen tests look for proteins ...
An antigen is any substance that causes your immune system to produce antibodies against it. This means your immune system does not recognize the substance, and is trying to fight it off. An antigen may be a substance from th
Immunogens are substances that can induce an immune response, while antigens are substances that can bind to antibodies or T-cell receptors. Not all antigens are immunogenic. The properties of an effective immunogen include foreignness, molecular size over 100,000 Daltons, chemical complexity, and the ability to be processed and presented by antigen-presenting cells. The immunogenicity of a substance depends on additional factors like dosage, route of administration, use of adjuvants, and host genetics. Antigens can be classified as exogenous, endogenous, autoantigens, or complete versus incomplete antigens.
Basic immunology- Dr.Pankti Shah (PART I MDS)PanktiShah12
This document provides an overview of immunology and the immune system as it relates to dental bacterial plaque and periodontitis. It defines key terms like immunity, antigens, antibodies, and the antigen-antibody reaction. It describes the different types of immunity and components of the immune system including the complement system. It discusses the inflammatory response in the periodontium and potential for periodontal vaccines. It also covers the immunology of dental bacterial plaque and the roles of antibodies, complement activation, chemotaxis, phagocytosis, and T and B lymphocytes in the immune response to caries, gingivitis and periodontitis.
Antigens, haptens and immunogens were discussed. Key points:
- Antigens are molecules that induce an immune response through binding antibodies or T cells. Immunogens can induce immune responses while antigens may only bind antibodies/T cells.
- Antigens are classified based on origin (exogenous, endogenous, autoantigens), chemical structure (proteins, polysaccharides etc.), and type of immune response generated (T cell dependent/independent).
- Immunogenicity depends on antigen properties like size, structure and degradability as well as the exposed biological system. Larger complex molecules tend to be more immunogenic.
This document discusses antigens and concepts in vaccine development. It begins by defining antigens and classifying them as exogenous or endogenous. It then discusses the differences between immunogenicity and antigenicity, and lists factors that influence immunogenicity such as molecular size, chemical composition, and adjuvants. The document also covers epitopes, mitogens, and superantigens. Finally, it discusses the different stages of vaccine development from pre-clinical to clinical trials and licensing, and methods used in vaccine manufacturing.
Antigens are substances that stimulate the immune system to produce antibodies. The smallest part of an antigen that induces an immune response is called an epitope. Antigens can be proteins, polysaccharides, lipids, or nucleic acids. Antigens must be foreign to induce an immune response, as the body develops tolerance to self antigens. Antibody molecules bind specifically to antigens. Antibodies belong to five classes - IgG, IgA, IgM, IgD, and IgE - which have different structures and functions such as neutralizing toxins, activating complement pathways, and aiding phagocytosis. Abnormal immunoglobulins can indicate diseases like multiple myeloma or cryoglobulinemia.
Antigen is a substance that stimulates the immune system to produce antibodies against it. Antigens can be proteins, polysaccharides, lipids, or nucleic acids. The ability of a substance to induce an immune response is called immunogenicity, while the ability to bind antibodies is called antigenicity. Factors like molecular size, complexity, shape, stability, and foreignness determine a substance's antigenicity. Antigens contain epitopes that antibodies and T cells recognize. Common antigens include microbial antigens from bacteria, viruses, and other microbes, as well as non-microbial antigens like pollen and snake venom.
This document provides an overview of antigen-antibody interactions and the immune response. It discusses how antigens activate B lymphocytes to produce antibodies, the structure and types of antibodies, and how antibodies function through direct interaction with antigens and activation of the complement system. It also describes clinical applications of immunization and passive immunity. Key topics covered include antigenicity, haptens, superantigens, primary versus secondary immune responses, and tests used to detect antigen-antibody reactions.
This document provides information on types of antigens and factors that determine antigenicity. It discusses different types of antigens, including exogenous, endogenous, autoantigens, and alloantigens. It also covers the chemical nature of antigens, including proteins, polysaccharides, nucleic acids, and lipids. Additionally, it examines factors that influence immunogenicity, such as foreignness, molecular size, chemical nature, physical form, antigen specificity, and others. Superantigens are also discussed as a class of antigens that cause non-specific polyclonal activation of T-cells.
This document summarizes key topics in immunology including:
- Innate and acquired immunity and the cells involved like T cells, B cells, and phagocytes.
- Antigens and antibodies and their specific reaction.
- Structure and function of the immune system including lymphoid organs and cells.
- Immune response mechanisms like phagocytosis, complement system, and antibody production.
- Types of immunity, vaccines, and factors affecting immunity.
This document discusses the immune system and immunology. It covers topics such as innate immunity, acquired immunity, antigens, antibodies, and the structure and function of the immune system. The key components of the immune system are described, including phagocytic cells, lymphocytes, and the lymphoreticular system. Different immune responses like humoral immunity and cell-mediated immunity are also summarized. The roles of antigens, antibodies, and their reactions are defined.
ANTIGEN & ANTIBODY AND THEIR REACTIONS Gayathri Nair
This document discusses antigens, antibodies, and antigen-antibody reactions. It defines antigens as molecules that can be recognized by B cells or T cells. Antibodies are globulin proteins that react specifically with antigens. The document outlines antibody structure, including heavy and light chains, variable and constant regions, and classes of immunoglobulins. It also describes antigen specificity, determinants, haptens, and superantigens.
This document provides an overview of the basics of immunity, including definitions of key terms, the roles and components of the immune system, and the different types of immunity. The immune system is made up of organs, cells, and molecules that work together to defend the body against pathogens. There are two main types of immunity - innate immunity, which provides a rapid initial response, and adaptive immunity, which has antigen-specific memory cells and antibodies that provide a stronger secondary response. The adaptive immune response involves both cell-mediated immunity by T cells and humoral immunity by B cells and antibodies.
Traditional versus Modern Biotechnology (Exam 2 coverage)Marilen Parungao
Traditional (classical) biotechnology includes fermentation, breeding, and the production of antibiotics and vaccines. Fermentation involves using microbes like yeast and bacteria to produce foods and beverages through anaerobic respiration, including beer, wine, cheese, bread and yogurt. Breeding techniques like inbreeding and crossbreeding were used to selectively develop plant and animal varieties with desirable traits. Early methods discovered antibiotics produced by microorganisms and used vaccines containing weakened or killed pathogens to trigger immune responses without causing illness.
This document discusses biodiversity, including its definition, levels, importance, threats, and status in the Philippines. It defines biodiversity as the variety of life on Earth, including diversity at the genetic, species, and ecosystem levels. The lecture notes cover the three main levels of biodiversity and provides examples. It emphasizes that biodiversity is important to preserve for economic, aesthetic, and scientific reasons. Major threats to biodiversity include habitat loss, overexploitation, climate change, pollution, and invasive species. The document concludes that the Philippines is one of the most biodiverse countries in the world, with over half of its plant and animal species being endemic.
Traditional (classical) biotechnology refers to techniques that have been used for thousands of years, such as fermentation processes. Key applications of fermentation included producing foods like beer, wine, cheese, bread and yogurt. These processes harness microbes like yeast and bacteria to convert sugars into products like ethanol, lactic acid, carbon dioxide and other compounds, allowing foods to be preserved and enhancing flavors. Traditional biotechnology built upon ancient techniques and helped enable major advances in food production and medicine.
Transcription must occur before translation because a ribosome needs an mRNA blueprint to construct a protein. The operator is activated when lactose binds to the lac repressor and inactivated when the lac repressor binds to the operator. The last line shows a sequence of mRNA codons.
Lecture on DNA to Proteins (The Central Dogma of Molecular Biology)Marilen Parungao
- Transcription must occur before translation. Transcription involves copying DNA into mRNA, which is then used as a template for translation.
- The LAC operon is activated under conditions where glucose is low/lactose is high. It is inactivated when glucose is high/lactose is low.
- The DNA sequence provided would be transcribed into an RNA sequence where all Ts would be replaced with Us: 3'-UAC GGC AUU GCA CAU UUU AGG GGC AAU AUU-5'
This document discusses nucleic acids and proteins, including their structures and functions. It provides information on DNA and RNA, such as their components, properties, and roles in coding for proteins. Key experiments that helped identify DNA as the genetic material are summarized, including Griffith's transformation experiment, Avery-MacLeod-McCarty experiment, and Hershey-Chase experiment. Questions are also included about nucleic acid and protein structures and these classic experiments.
The document discusses nutrient cycling and biogeochemical cycles. It explains that nutrients are transported through organisms, atmosphere, water, and land in a series of cycles. The main cycles discussed are the water, oxygen, carbon, nitrogen, phosphorus, and sulfur cycles. It describes the reservoirs, chemical forms, and processes involved in each cycle. It also addresses how human activities like pollution, use of fertilizers, and deforestation can disrupt nutrient cycling and cause issues like eutrophication, ozone depletion, and acid rain. Potential solutions to remediate disrupted cycles, like bioremediation using bacteria, fungi, plants and algae, are also mentioned.
This document provides an overview of Gregor Mendel's experiments with pea plants and the principles of heredity and genetics that he discovered. It discusses Mendel's work crossing pea plants with different traits, such as flower color, and recording the results in subsequent generations. His experiments showed that traits are inherited in discrete units (now known as genes) and follow predictable patterns, such as the 3:1 ratio he observed for dominant and recessive traits in the F2 generation of a monohybrid cross. The document also covers Mendel's principle of independent assortment observed in dihybrid crosses.
The document contains a calendar of activities for Marilen M. Parungao-Balolong covering topics such as calendar of activities, energy concepts and energy flow, ecology, ecosystem concepts, and energy flow, with each topic containing multiple entries attributed to Marilen M. Parungao-Balolong.
The document contains the calendar of activities and lecture notes from a biology class taught by Marilen M. Parungao-Balolong. The lecture covers the fundamentals of chemistry of life, including atoms, chemical bonds, important biological molecules like carbohydrates, lipids, proteins and nucleic acids. It also discusses the domains of life including viruses, prokaryotes and eukaryotes. The functional anatomy of different cell types like plant, animal, bacterial and yeast cells are presented. The lecture concludes with topics on metabolism, catabolism, anabolism, cellular respiration and fermentation.
The document discusses different perceptions of and approaches to nature and the environment. It outlines major perceptions like everything being connected or nature having a delicate balance. It then discusses environmental ethics and different world views like biocentrism, ecocentrism, and anthropocentrism. Biocentrism and ecocentrism view humans as part of the environment, while anthropocentrism views nature as existing for human use. The document argues that anthropocentric views can lead to problems like overpopulation. It suggests adopting more ecocentric values to better care for the environment. Finally, it defines environmental justice as the fair treatment of all people regarding environmental laws and policies.
This document provides an introduction and overview of biotechnology, including definitions of key terms and an historical timeline of important developments in the field. It begins with definitions of biotechnology and genetic engineering. It then outlines the timeline of biotechnology from early domestication and farming in Mesopotamia through modern developments like recombinant vaccines, cloning, and the human genome project. The document concludes with a note about an upcoming meeting to level off on the material.
This document outlines the activities and requirements for a course on biotechnology. It includes lectures, presentations, exams, lab activities and field trips. There will be three exams covering introduction to techniques, applications of biotechnology, and international laws and guidelines. Students will work in groups to present on developing a GMO and create an exhibit for BioWeek. The course will also include virtual laboratory activities covering DNA extraction, PCR, gel electrophoresis, and microarrays. The last meeting will discuss isolating genes from plants and animals as well as human cloning and stem cell research.
The document outlines the content of a lecture on modern biotechnology. It discusses DNA as the genetic material and how genes are passed from parents to offspring in prokaryotic and eukaryotic systems. It also describes how modern biotechnology uses techniques like gene cloning and genetic engineering to develop genetically modified organisms (GMOs) by inserting foreign genes. Specific examples covered include the development of Golden Rice to address vitamin A deficiency and the use of GMOs in health, industry, food, and the environment.
The document discusses the history and development of vaccines from Edward Jenner's pioneering smallpox vaccine in the 18th century to modern vaccines. It covers key topics such as passive and active immunity, commonly used vaccine types including live attenuated, killed/inactivated, subunit/component, toxoid, and DNA vaccines. Safety considerations, efficacy, target groups, and monitoring of vaccine effects are also addressed.
This document provides an overview of controlling microbial growth through various physical and chemical methods. It defines key terms like sterilization, disinfection, sanitization, and antisepsis. Physical methods discussed include heat, radiation, filtration, and desiccation. Chemical methods include sterilants, disinfectants, sanitizers, antiseptics, and preservatives. The document also discusses factors that influence the effectiveness of antimicrobial agents and how their modes of action include damaging membranes, proteins, and nucleic acids. Assessment methods for disinfectants and chemotherapeutic agents like the phenol coefficient test, agar diffusion method, and minimum inhibitory concentration are also summarized.
Microbial growth refers to an increase in the number of microbial cells rather than an increase in cell size. Microbes require certain physical, chemical and nutritional conditions to grow, including a source of carbon, nitrogen, phosphorus and other trace elements. Temperature, pH, oxygen levels and osmotic pressure also influence microbial growth. Pure cultures can be obtained through streak plating and maintained through subculturing or freezing methods like glycerol stocks.
This document contains calendars of activities for Biology 196 for two sections, TBYZ and FBYZ, listing dates from August to October, with speakers, facilitators, and reactors assigned for each date. Students are scheduled to fulfill each role on different dates. The same activity of submitting a review paper to the teacher and reactor is listed for August 14 for both sections.
The document discusses whether microbe extinction should be cared about. It notes that while over 99% of species that have ever lived are extinct, microbes are ubiquitous and diverse. However, their roles in biogeochemical cycles and symbiotic relationships mean local extinctions could have large impacts. Evidence suggests microbes can face extinction through habitat loss, pollution, and climate change. Their potential losses through these human-caused threats to ecosystems should be a concern.
The document discusses the definition and requirements for microbial growth. Microbial growth is defined as an increase in the number of cells rather than cell size. The key requirements for microbial growth include physical factors like temperature, pH, and osmotic pressure as well as chemical nutrients like carbon, nitrogen, sulfur, phosphorus, trace elements, oxygen, and organic growth factors. Different microbes have different temperature, pH, and osmotic pressure preferences and obtain nutrients from various sources.
Dandelion Hashtable: beyond billion requests per second on a commodity serverAntonios Katsarakis
This slide deck presents DLHT, a concurrent in-memory hashtable. Despite efforts to optimize hashtables, that go as far as sacrificing core functionality, state-of-the-art designs still incur multiple memory accesses per request and block request processing in three cases. First, most hashtables block while waiting for data to be retrieved from memory. Second, open-addressing designs, which represent the current state-of-the-art, either cannot free index slots on deletes or must block all requests to do so. Third, index resizes block every request until all objects are copied to the new index. Defying folklore wisdom, DLHT forgoes open-addressing and adopts a fully-featured and memory-aware closed-addressing design based on bounded cache-line-chaining. This design offers lock-free index operations and deletes that free slots instantly, (2) completes most requests with a single memory access, (3) utilizes software prefetching to hide memory latencies, and (4) employs a novel non-blocking and parallel resizing. In a commodity server and a memory-resident workload, DLHT surpasses 1.6B requests per second and provides 3.5x (12x) the throughput of the state-of-the-art closed-addressing (open-addressing) resizable hashtable on Gets (Deletes).
Your One-Stop Shop for Python Success: Top 10 US Python Development Providersakankshawande
Simplify your search for a reliable Python development partner! This list presents the top 10 trusted US providers offering comprehensive Python development services, ensuring your project's success from conception to completion.
Monitoring and Managing Anomaly Detection on OpenShift.pdfTosin Akinosho
Monitoring and Managing Anomaly Detection on OpenShift
Overview
Dive into the world of anomaly detection on edge devices with our comprehensive hands-on tutorial. This SlideShare presentation will guide you through the entire process, from data collection and model training to edge deployment and real-time monitoring. Perfect for those looking to implement robust anomaly detection systems on resource-constrained IoT/edge devices.
Key Topics Covered
1. Introduction to Anomaly Detection
- Understand the fundamentals of anomaly detection and its importance in identifying unusual behavior or failures in systems.
2. Understanding Edge (IoT)
- Learn about edge computing and IoT, and how they enable real-time data processing and decision-making at the source.
3. What is ArgoCD?
- Discover ArgoCD, a declarative, GitOps continuous delivery tool for Kubernetes, and its role in deploying applications on edge devices.
4. Deployment Using ArgoCD for Edge Devices
- Step-by-step guide on deploying anomaly detection models on edge devices using ArgoCD.
5. Introduction to Apache Kafka and S3
- Explore Apache Kafka for real-time data streaming and Amazon S3 for scalable storage solutions.
6. Viewing Kafka Messages in the Data Lake
- Learn how to view and analyze Kafka messages stored in a data lake for better insights.
7. What is Prometheus?
- Get to know Prometheus, an open-source monitoring and alerting toolkit, and its application in monitoring edge devices.
8. Monitoring Application Metrics with Prometheus
- Detailed instructions on setting up Prometheus to monitor the performance and health of your anomaly detection system.
9. What is Camel K?
- Introduction to Camel K, a lightweight integration framework built on Apache Camel, designed for Kubernetes.
10. Configuring Camel K Integrations for Data Pipelines
- Learn how to configure Camel K for seamless data pipeline integrations in your anomaly detection workflow.
11. What is a Jupyter Notebook?
- Overview of Jupyter Notebooks, an open-source web application for creating and sharing documents with live code, equations, visualizations, and narrative text.
12. Jupyter Notebooks with Code Examples
- Hands-on examples and code snippets in Jupyter Notebooks to help you implement and test anomaly detection models.
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-und-domino-lizenzkostenreduzierung-in-der-welt-von-dlau/
DLAU und die Lizenzen nach dem CCB- und CCX-Modell sind für viele in der HCL-Community seit letztem Jahr ein heißes Thema. Als Notes- oder Domino-Kunde haben Sie vielleicht mit unerwartet hohen Benutzerzahlen und Lizenzgebühren zu kämpfen. Sie fragen sich vielleicht, wie diese neue Art der Lizenzierung funktioniert und welchen Nutzen sie Ihnen bringt. Vor allem wollen Sie sicherlich Ihr Budget einhalten und Kosten sparen, wo immer möglich. Das verstehen wir und wir möchten Ihnen dabei helfen!
Wir erklären Ihnen, wie Sie häufige Konfigurationsprobleme lösen können, die dazu führen können, dass mehr Benutzer gezählt werden als nötig, und wie Sie überflüssige oder ungenutzte Konten identifizieren und entfernen können, um Geld zu sparen. Es gibt auch einige Ansätze, die zu unnötigen Ausgaben führen können, z. B. wenn ein Personendokument anstelle eines Mail-Ins für geteilte Mailboxen verwendet wird. Wir zeigen Ihnen solche Fälle und deren Lösungen. Und natürlich erklären wir Ihnen das neue Lizenzmodell.
Nehmen Sie an diesem Webinar teil, bei dem HCL-Ambassador Marc Thomas und Gastredner Franz Walder Ihnen diese neue Welt näherbringen. Es vermittelt Ihnen die Tools und das Know-how, um den Überblick zu bewahren. Sie werden in der Lage sein, Ihre Kosten durch eine optimierte Domino-Konfiguration zu reduzieren und auch in Zukunft gering zu halten.
Diese Themen werden behandelt
- Reduzierung der Lizenzkosten durch Auffinden und Beheben von Fehlkonfigurationen und überflüssigen Konten
- Wie funktionieren CCB- und CCX-Lizenzen wirklich?
- Verstehen des DLAU-Tools und wie man es am besten nutzt
- Tipps für häufige Problembereiche, wie z. B. Team-Postfächer, Funktions-/Testbenutzer usw.
- Praxisbeispiele und Best Practices zum sofortigen Umsetzen
[OReilly Superstream] Occupy the Space: A grassroots guide to engineering (an...Jason Yip
The typical problem in product engineering is not bad strategy, so much as “no strategy”. This leads to confusion, lack of motivation, and incoherent action. The next time you look for a strategy and find an empty space, instead of waiting for it to be filled, I will show you how to fill it in yourself. If you’re wrong, it forces a correction. If you’re right, it helps create focus. I’ll share how I’ve approached this in the past, both what works and lessons for what didn’t work so well.
In the realm of cybersecurity, offensive security practices act as a critical shield. By simulating real-world attacks in a controlled environment, these techniques expose vulnerabilities before malicious actors can exploit them. This proactive approach allows manufacturers to identify and fix weaknesses, significantly enhancing system security.
This presentation delves into the development of a system designed to mimic Galileo's Open Service signal using software-defined radio (SDR) technology. We'll begin with a foundational overview of both Global Navigation Satellite Systems (GNSS) and the intricacies of digital signal processing.
The presentation culminates in a live demonstration. We'll showcase the manipulation of Galileo's Open Service pilot signal, simulating an attack on various software and hardware systems. This practical demonstration serves to highlight the potential consequences of unaddressed vulnerabilities, emphasizing the importance of offensive security practices in safeguarding critical infrastructure.
zkStudyClub - LatticeFold: A Lattice-based Folding Scheme and its Application...Alex Pruden
Folding is a recent technique for building efficient recursive SNARKs. Several elegant folding protocols have been proposed, such as Nova, Supernova, Hypernova, Protostar, and others. However, all of them rely on an additively homomorphic commitment scheme based on discrete log, and are therefore not post-quantum secure. In this work we present LatticeFold, the first lattice-based folding protocol based on the Module SIS problem. This folding protocol naturally leads to an efficient recursive lattice-based SNARK and an efficient PCD scheme. LatticeFold supports folding low-degree relations, such as R1CS, as well as high-degree relations, such as CCS. The key challenge is to construct a secure folding protocol that works with the Ajtai commitment scheme. The difficulty, is ensuring that extracted witnesses are low norm through many rounds of folding. We present a novel technique using the sumcheck protocol to ensure that extracted witnesses are always low norm no matter how many rounds of folding are used. Our evaluation of the final proof system suggests that it is as performant as Hypernova, while providing post-quantum security.
Paper Link: https://eprint.iacr.org/2024/257
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-EfficiencyScyllaDB
Freshworks creates AI-boosted business software that helps employees work more efficiently and effectively. Managing data across multiple RDBMS and NoSQL databases was already a challenge at their current scale. To prepare for 10X growth, they knew it was time to rethink their database strategy. Learn how they architected a solution that would simplify scaling while keeping costs under control.
Digital Marketing Trends in 2024 | Guide for Staying AheadWask
https://www.wask.co/ebooks/digital-marketing-trends-in-2024
Feeling lost in the digital marketing whirlwind of 2024? Technology is changing, consumer habits are evolving, and staying ahead of the curve feels like a never-ending pursuit. This e-book is your compass. Dive into actionable insights to handle the complexities of modern marketing. From hyper-personalization to the power of user-generated content, learn how to build long-term relationships with your audience and unlock the secrets to success in the ever-shifting digital landscape.
What is an RPA CoE? Session 1 – CoE VisionDianaGray10
In the first session, we will review the organization's vision and how this has an impact on the COE Structure.
Topics covered:
• The role of a steering committee
• How do the organization’s priorities determine CoE Structure?
Speaker:
Chris Bolin, Senior Intelligent Automation Architect Anika Systems
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfChart Kalyan
A Mix Chart displays historical data of numbers in a graphical or tabular form. The Kalyan Rajdhani Mix Chart specifically shows the results of a sequence of numbers over different periods.
Introduction of Cybersecurity with OSS at Code Europe 2024Hiroshi SHIBATA
I develop the Ruby programming language, RubyGems, and Bundler, which are package managers for Ruby. Today, I will introduce how to enhance the security of your application using open-source software (OSS) examples from Ruby and RubyGems.
The first topic is CVE (Common Vulnerabilities and Exposures). I have published CVEs many times. But what exactly is a CVE? I'll provide a basic understanding of CVEs and explain how to detect and handle vulnerabilities in OSS.
Next, let's discuss package managers. Package managers play a critical role in the OSS ecosystem. I'll explain how to manage library dependencies in your application.
I'll share insights into how the Ruby and RubyGems core team works to keep our ecosystem safe. By the end of this talk, you'll have a better understanding of how to safeguard your code.
3. What are antigens?
• any molecule that can bind
specifically to an antibody
• substances that can be recognized by
the immunoglobulin receptor of B cells
or by the T-cell receptor when
complexed with MHC
• name arises from their ability to
generate antibodies
Monday, June 25, 2012
4. What are antigens?
• includes sugars, lipids, intermediary
metabolites, hormones, complex
carbohydrates, phospholipids, nucleic
acids and proteins
• found in surface or parts of a microbe
or from the environment (e.g. food,
pollen, etc)
Monday, June 25, 2012
5. Immunologic
Properties of Antigens
• Allergenicity:
• having the capacity to induce allergy
(hypersensitivity)
• Tolerogenicity:
• capable of inducing immunological tolerance
(immune system does not attack the antigen)
• Immunogenicity*
• Antigenicity*
Monday, June 25, 2012
9. Antigens and Immunogens
• ANTIGEN
• A molecule which can be specifically recognized and bound
by an antibody
• “Antigenic”
• IMMUNOGEN
• A molecule which can elicit the production of specific
antibody upon injection into a suitable host
• “Immunogenic”
• ALL molecules that are immunogenic are also antigenic..BUT...not
all antigenic molecules are immunogenic! (Example: HAPTENS!)
Monday, June 25, 2012
10. Antigens: Haptens &
Immunogens
• HAPTENS (incomplete antigen)
• antigens that by themselves do not elicit antibody
production
• unable to induce an immune response alone
but able to react with products (Abs)
• have the property of antigenicity but not
immunogenicity (elicit immune response)
• NOTE: could be rendered immunogenic by covalently
linking them to a carrier molecule
Monday, June 25, 2012
13. Antigens: Haptens &
Immunogens
• IMMUNOGENS (complete antigen)
• antigens that can elicit antibody production
• stimulate B and/or T cell arms of the immune
response and react with products (Abs)
• both induces an immune response and
reacts with the products of it (Abs)
Monday, June 25, 2012
14. Factors that Influence
Immunogenicity
• Nature of the Immunogen
• foreignness
• molecular size
• chemical composition and heterogeneity
• lipids as antigens
• susceptibility to antigen processing and presentation
Monday, June 25, 2012
15. Foreigness
• Recall: “in order to elicit an immune response, a
molecule must be recognized as NON-SELF by the
biological system”
• tolerance for SELF-antigens
• The greater the phylogenetic distance between two
species, the greater the structural disparity between
them
• EXAMPLE: bovine serum albumin not immunogenic
to cow bt is on chicken (cow > goat > chicken)
Monday, June 25, 2012
16. Molecular Size
• The most ACTIVE immunogens:
• 100,000 Da
• Substances with a molecular mass of
5,000-10,000 Da are poor immunogens
• EXEMPTIONS: few substances with a
molecular mass less than 1,000 Da have
proven to be immunogenic
Monday, June 25, 2012
17. Chemical Composition
& Heterogeneity
• chemical
complexity
contributes to
immunogenicity
Monday, June 25, 2012
18. Lipids as Antigens
• appropriately presented lipoidal
antigens can induce both B-cell and
T-cell responses
• Example: lipid-protein conjugates
(lipids are used as haptens)
Monday, June 25, 2012
20. Susceptibility to Antigen
Presentation & Processing
• the development of both humoral and cell-mediated
immune responses requires interaction of T-cells with
antigen that has been processed and presented together
with MHC molecules
• LARGE, INSOLUBLE macromolecules are generally more
immunogenic than SMALL, SOLUBLE ones
• larger molecules are more readily phagocytosed and
processed
• degradative enzymes within antigen-presenting cells can
degrade only proteins containing L-amino acids, polymers of
D-amino acids cannot be processed
Monday, June 25, 2012
21. Factors that Influence
Immunogenicity
•Biological System
• genotype of the recipient animal
• immunogen dosage and and route of
administration
• adjuvants
Monday, June 25, 2012
22. Genotype of
Recipient Animal
• MHC gene products = determines the degree
to which an animal responds to an immunogen
(immune responsiveness)
• response influenced by genes that encode B-cell
and T-cell receptors
• response influenced by genes that encode
various proteins involved in immune regulatory
mechanisms
• THUS: genetic variability affects
immunogenicity in different animals
Monday, June 25, 2012
23. Dosage and Route
• experimental immunogen exhibits unique dose-
response curve
• DOSE
• insufficient dose will not stimulate an immune
response (fails to activate lymphocytes or
tolerance)
• excessively high dose = tolerance
• THUS....repeated adminsitrations or BOOSTERS
are done if a single dose will not induce a strong
response = increase clonal proliferation of antigen-
specific T cells or B-cells = increase the lymphocyte
populations SPECIFIC for the immunogen
Monday, June 25, 2012
24. Dosage and Route
• experimental immunogen exhibits unique dose-response curve
• ROUTE
• generally administered parenterally = other than the GIT
• Subcutaneous route > Intramuscular > Intraperitoneal >
Intraveous > Oral route
• Can you recall the route of your vaccine shots?
• strongly influence which immune organs and cell populations will be
involved in the response
• intravenous = carried first to the spleen
• subcutaneous = moves first to local lymph nodes
Monday, June 25, 2012
25. Adjuvants
• substances that, when mixed with an
antigen and injected with it, ENHANCE
the immunogenicity of that antigen
• used to boost the immune response when
an antigen has LOW IMMUNOGENICITY
or when only SMALL AMOUNTS of an
antigen is available
Monday, June 25, 2012
27. IN SUMMARY...
Parameter Increased Decreased
Immunogenicity Immunogenicity
Size Large >10,000; Small MW<2500
best >100,000
Dose Intermediate High or Low
Route Subcutaneous/IM > Intravenous > Oral or
Intraperitoneal > intragastric
Composition Complex Simple
Form Particulate Soluble
Denatured Native
Similarity to self proteins Multiple differences Few differences
Adjuvants Slow release Rapid release
Bacteria No bacteria
Interaction with host MHC Effective Ineffective
Monday, June 25, 2012
28. EPITOPES:
Antigenic Determinants
Monday, June 25, 2012
29. Antigenic Determinants
or Epitopes
• DEFINITION:
• immunologically active regions of an immunogen that interacts with the
specific antigen binding site in the variable region of the antibody molecule
(PARATOPE) or to secreted antibodies
• EXCELLENT FIT between epitope and paratope: based upon their 3-D
interaction and non covalent union
• are discrete site on the macromolecule recognized by the lymphocytes (B-
lymphocytes/ T-lymphocytes)
• NOTE: B and T cells recognize DIFFERENT epitopes on the SAME antigenic
molecule
• THUS: the ability to function as a B-cell epitope is determined by the
nature of the ANTIGEN-BINDING site of the antibody molecules
DISPLAYED by B-cells
Monday, June 25, 2012
30. Antigenic Determinants
or Epitopes
• An antigen molecule has 2 or more epitopes or antigenic determinants per
molecule
• Epitopes consist of approximately 6 amino acids or 6 monosaccharides
• Immunodominant Epitope: stimulate a greater antibody response
Monday, June 25, 2012
32. APPLICATIONS:
Epitope Mapping
• Assignment: Diagram an experiment on how to
carry out epitope mapping and determination of
epitopes
• QUESTION: How will you know which fraction/
epitope will be the most highly immunogenic/
antigenic?
• Handwritten: Yellow Paper to be submiited
on Tuesday
Monday, June 25, 2012
33. Antigen Classification
• T cell dependent Ags or TD
• much more complex than TI
Ags
• usually proteins
• stimulate a full complement of
immunoglobulins with all five
classes represented
• elicit an anamnestic or
memory response & are
present in most pathogenic
organisms
Monday, June 25, 2012
34. Viral proteins = HA and NA
bacterial protein = flagellin
Fungal proteins = keratinases
Monday, June 25, 2012
35. Antigen Classification
•T cell independent
Ags or TI
• often polysaccharides
or
lipopolysaccharides
• elicit an IgM response
only and fail to
stimulate an amnestic
response
Monday, June 25, 2012
37. Example: Fungi
Group of fungi Fungi Polysaccharide Ag (TI) Protein Ag (TD)
Molds Aspergillus galactomannan glycoproteins
Yeasts Candida albicans Alpha mannan proteinase
Yeasts Cryptococcus neoformans galactoxylomannan
Dermatophytes Trichophyton Galactomannan peptides Keratinases I, II. III
Zygomycetes Rhizopus peptidofucomannan Proteinase
Dimorphic systemic fungi Histoplasma capsulatum galactomannan “h” & ‘m” factors
“ Paracoccodioides galactomannan E2 factor
“ Coccidioides imitis Methyl-mannose polymer Coccidiodin factor
Subcutaneous Sporothrix schenckii Peptido-L-rhamno-D-mannan
Monday, June 25, 2012
38. Summary of Antigen Classification
Thymus dependent Thymus independent
Structural Complex Simple
properties
Chemistry Proteins; protein- Polysaccharide of
nucleoprotein conjugates; pneumococcus; dextran
glycoproteins; polyvinyl pyrolidone;
lipoproteins bacterial Lipolysaccharide
Antibody class IgG, IgM, IgA, IgM
induced (+ IgD and IgE)
Immunological YES NO
memory response
Present in most YES NO
pathogenic
microbes
Monday, June 25, 2012
39. Superantigens
• a substance such as a bacterial toxin capable of stimulating MANY
CD4+ T lymphocytes leading to the release of relatively large
quantities of cytokines that provoke pathophysiologic manifestations
• NOTE: Superantigens are TD antigens = THUS, Do not
require phagocyte processing
• stimulate multiple T cells that augment a protective T & B cell
response
Monday, June 25, 2012
41. Superantigens
• Examples:
• Staphylococcal enterotoxins (food poisoning)
• Staphylococcal toxic shock toxin (toxic shock
syndrome)
• Staphylococcal exfoliating toxins (scalded skin
syndrome)
• Streptococcal pyrogenic exotoxins (shock)
• The diseases associated with exposure to
superantigens are, in part, due to hyper activation
of the immune system and subsequent release of
biologically active cytokines by activated T cells
Monday, June 25, 2012
42. Mitogens
• substance, often derived from plants, that
causes DNA synthesis and induces blast
transformation and division by mitosis
• Lectins, representing plant-derived
mitogens or phytomitogens are used in
experimental and clinical immunology to
evaluate T and B lymphocyte function in vitro
Monday, June 25, 2012
43. Mitogens
Characteristic Concanavalin A Phytohemagglu Pokeweed
(Con A) tinin (PHA) mitogen
(PWM)
Source Jack beans Kidney beans Pokeweed
Molecular Tetramer Tetramer Polymeric
Structure
Ligand A-D-mannose & a- N- Di-N-
D-glucose acetylgalactosamine acetylchitobiose
Target cell/s T cells T cells T cells and B cells
Monday, June 25, 2012
44. SPECIAL ISSUE:
Antigenic Variation
Monday, June 25, 2012
49. ANTIBODIES
(Immunoglobulins or Igs)
Monday, June 25, 2012
50. What are antibodies?
• Antibodies : antigen-binding proteins present on
the B-cell membrane and secreted by plasma
cells
• when bound confers antigenic specificity on B-cells
• Common to all antibodies:
• structural features
• binds to antigen
• participate in effector function
Monday, June 25, 2012
52. Ab-mediated Effector Functions
• Opsonization: promotion of phagocytosis
of antigens by macrophages and nuetrophils
• Fc receptors (in surfaces of macrophages and
nuetrophils) bind to Ig molecules which
induces a signal transduction pathway
resulting in phagocytosis of the Ag-Ab
complex
• Actions: enzymatic digestion, oxidative
damage, membrane-disrupting effects of
bacterial peptides
Monday, June 25, 2012
54. Ab-mediated Effector Functions
• Complement Activation (IgM and
IgG): induces a collection of proteins that
can perforate cell membranes
• C3b: important by-product; binds non-
specifically to cell and Ag-Ab complexes
• many cell types have receptors for C3b (e.g.
macrophages leading to phagocytosis)
• significance: removal and killing of pathogens
Monday, June 25, 2012
55. Ab-mediated Effector Functions
• Antibody-dependent cell-mediated
Cytotoxicity (ADCC): kills cells
• Ab acts as a newly acquired receptor
enabling the attacking cell to recognize and
kill the target cell
• Pre-requisite: linking of Ab bound to target
cells (e.g. virus in host cells) with the Fc
receptor of many cell types can direct the
cytotoxic activities of the effector cell against
the target cell
Monday, June 25, 2012
57. Basic Structure of Antibodies
• Antibodies found in
serum protein fractions
• electrophoretic mobility
revealed four peaks:
albumin, alpha, beta and
gamma
• Gamma globulin factors
= immunoglobulins (IgG)
which contains serum
antibodies
Monday, June 25, 2012
58. Antibodies are Heterodimers
• consist of two identical
side light chains & two
identical heavy chains
linked by disulfide bonds
• heavy chain: has an
amino-terminal variable
region followed by a
constant region
Monday, June 25, 2012
60. Immunoglobulin Classes
• in any given antibody
molecule, the constant
region contains one of
five basic heavy chain
sequences called
isotypes
• the heavy chain
isotype determines
the class of an
antibody
Monday, June 25, 2012
64. Antibody Classes : IgG
• PROPERTIES:
• major serum immunoglobulins (systemic immunity)
• major immunoglobulin in extravascular spaces
• does not require antigen binding during placental
transfer (IgG2)
• fixes complement (IgG4)
• binds to Fc receptors (iGg2 and IgG4)
• phagocytes - opsonization
• Killer cells - ADCC
Monday, June 25, 2012
65. Antibody Classes : IgM
• PROPERTIES
• pentamer
• 3rd highest serum
immunoglobulin
• first immunoglobulin made by
fetus and B cells C1r C1
s
• fixes complement C1q
C1r C1
s
• Figure: fixation of C1 by IgG C1q
and IgM
•
No activation Activation
agglutinating immunoglobulin
• binds to Fc receptors
• B-cell surface immunoglobulins
Monday, June 25, 2012
67. Antibody Classes : IgA
PROPERTIES OF IgA
• serum monomer
• secretions (sIgA)
• 2nd highest serum Secretory Piece J Chain
immunoglobulins
• major secretory Ig (tears, saliva,
gastric and pulmonary secretions)
= mucous and local immunity
• DO NOT fix complement (unless
aggregated
• binds to Fc receptors on some cells
Monday, June 25, 2012
68. Antibody
Classes : IgA
FORMATION OF
SECRETORY IgA
Monday, June 25, 2012
70. Antibody Classes : IgD
PROPERTIES OF IgD
• monomer
• tail piece
• 4th highest serum Ig
• B-cell surface Ig Tail Piece
• DOES NOT BIND
complement
Monday, June 25, 2012
71. Antibody Classes : IgE
PROPERTIES OF IgE
• monomer
• with extra domain
• least common serum Ig
• binds to basophils and mast cells (DO NOT
require antigen binding)
• allergic reaction
C!4
• parasitic infections (helminths)
• binds to Fc receptors on eosinophils
• DOES NOT fix complement
Monday, June 25, 2012
72. Allergies
IMMUNOGLOBULINS &
ALLERGIES
Monday, June 25, 2012
73. Biology 151
Introduction to Immunology
Georges Kohler and MONOCLONAL
Cesar Milstein in 1975 ANTIBODIES
Polyclonal antibodies :
arise from MANY B-
cell clones and have a
HETEROGENOUS
collection of binding
sites
Monoclonal
antibodies : derived
from a SINGLE B-cell
clone and is a
HOMOGENOUS
collection of binding
sites
Monday, June 25, 2012
74. Biology 151
Introduction to Immunology
CLINICAL UTILITY OF
MONOCLONAL
ANTIBODIES
Monday, June 25, 2012
75. Biology 151
Introduction to Immunology
CLINICAL UTILITY OF MONOCLONAL ANTIBODIES
•
DIAGNOSTICS:
detect small amounts of drugs, toxins or hormones, e.g. monoclonal antibodies to human chorionic
gonadotropin (HCG) are used in pregnancy test kits (Biotech, 1989); diagnosis of AIDS by the ELISA test.
•
THERAPEUTICS:
radioimmunodetection and radioimmunotherapy of cancer, and some new methods can even target only the cell
membranes of cancerous cells (Chaudhari et al, 1994);
cancer drug based on monoclonal antibody technology = Ritoxin, approved by the FDA in November 1997
(Orrs, 1997)
radioimmunodetection and radioimmunotherapy of cancer, and some new methods can even target only the cell
membranes of cancerous cells (Chaudhari et al, 1994); cancer drug based on monoclonal antibody
technology = Ritoxin, approved by the FDA in November 1997 (Orrs, 1997)
viral diseases, traditionally considered "untreatable" = AIDS (P/S/L, 1997).
•
TRANSPLANTATION
OKT3, an antibody to the T3 antigen of T cells, is used to alleviate the problem of organ rejection in patients
who have had organ transplants (Transweb, 1996).
Parungao-Balolong 2010
Monday, June 25, 2012
76. Biology 151
Introduction to Immunology
NEXT MEETING
Innate and Adaptive
Response
Monday, June 25, 2012